Sclerosis: all 3,103 studies
Page 25 of 32. Open to participants first (314), then studies with results posted, then the rest; newest registration first within each.
- Investigation of GM Pathology Using Ultra High Field (7T) MRI ScannerStatus unknownNCT01805986
- Clinical Trial of Probiotics in Systemic Sclerosis Associated Gastrointestinal DiseaseStatus unknownNCT01804959Phase 2
- Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal PopulationCompletedNCT01804660
- Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis DiseaseCompletedNCT01804647
- An Intravenous Infusion Study of rHIgM22 in Patients With Multiple SclerosisCompletedNCT01803867Phase 1
- Amiloride Clinical Trial In Optic NeuritisCompletedNCT01802489Phase 2
- Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple SclerosisCompletedNCT01795872Phase 4
- Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With FingolimodTerminatedNCT01790269
- IVIG Treatment in Systemic SclerosisStatus unknownNCT01785056Not applicable
- The Effect of Aerobic Exercise on Cognitive Function and Sleep Quality in Individuals With Multiple SclerosisCompletedNCT01783665Not applicable
- Examining the Effects of Video-game Exercise on Mobility and Brain Plasticity in Individuals With Multiple SclerosisCompletedNCT01780792Not applicable
- Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)CompletedNCT01780441
- Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01777646Phase 2
- Safety and Efficacy on Spasticity Symptoms of a Cannabis Sativa Extract in Motor Neuron DiseaseCompletedNCT01776970Phase 2/3
- Serial Collection of Primary Progressive Multiple Sclerosis Participants in the MURDOCK StudyCompletedNCT01776060
- Respiratory Function and Walking Capacity in Multiple SclerosisCompletedNCT01774201Not applicable
- Optical Coherence Tomography in Multiple Sclerosis PatientsCompletedNCT01774123
- Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?CompletedNCT01772888
- Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple SclerosisCompletedNCT01772199Phase 2
- Supraspinal Control of Lower Urinary Tract Function in Healthy Controls and Patients With Bladder DysfunctionCompletedNCT01768910Not applicable
- Vitamine D in Multiple SclerosisStatus unknownNCT01768039Phase 3
- Potential EEG Biomarkers and Antiepileptogenic Strategies for Epilepsy in TSCCompletedNCT01767779
- Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on BetaferonCompletedNCT01766063
- Evaluation of Safety, Tolerability, and PK of VX15/2503 In Patients With MSCompletedNCT01764737Phase 1
- Effects of Cognitive Behavioural Therapy and Exercise on Stress and Cognitive Deficits in Multiple SclerosisCompletedNCT01763983Not applicable
- Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral SclerosisCompletedNCT01758510Phase 1
- Expiratory Muscle Conditioning in Multiple Sclerosis Using Magnetic StimulationCompletedNCT01758224Not applicable
- Long-term Effect of Fingolimod on Circulating Immunocompetent Mononuclear Cells in Patients With Multiple SclerosisTerminatedNCT01755871Phase 4
- Role of Vitamin D in Reducing the Relapse Rate in Patients With Multiple SclerosisStatus unknownNCT01753375Phase 2
- Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple SclerosisCompletedNCT01749943
- Non-invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) Using the iVAPS ModeCompletedNCT01746381Not applicable
- Sleep Apnea in Multiple Sclerosis Positive Airway Pressure TrialCompletedNCT01746342Not applicable
- Mesenchymal Cells From Autologous Bone Marrow, Administered Intravenously in Patients Diagnosed With Multiple SclerosisCompletedNCT01745783Phase 1/2
- The Efficacy of EMDR in Patients With PTSD in Multiple SclerosisStatus unknownNCT01743664Phase 3
- Dose-finding Study of MT-1303CompletedNCT01742052Phase 2
- A Pilot Study to Assess microRNA Biomarkers in Early and Later Stage Multiple SclerosisCompletedNCT01737372
- Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral SclerosisStatus unknownNCT01730716Phase 2
- Mesenchymal Stem Cells for Multiple SclerosisCompletedNCT01730547Phase 1/2
- Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis ComplexStatus unknownNCT01730209Phase 2/3
- Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated SyndromeCompletedNCT01728922Phase 1/2
- The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis CohortCompletedNCT01723709
- Analyze the Myelin-TRAP as Diagnostic Tool in Multiple SclerosisTerminatedNCT01723631Not applicable
- Efficiency of 4-aminopyridin (Fampyra) on Gait, Vision, Cognition, Fatigue and Micturation in Patients With Multiple SclerosisStatus unknownNCT01720849
- Intrathecal Therapy With Monoclonal Antibodies in Progressive Multiple SclerosisCompletedNCT01719159Phase 2
- Effect of Melatonin on Multiple Sclerosis Related FatigueCompletedNCT01718678Phase 2
- Rehabilitation in Multiple Sclerosis: Influence of Exercise on Development of Insulin Resistance, Muscle Power and Aerobic CapacityCompletedNCT01718392Not applicable
- Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT01717664Phase 2
- Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple SclerosisWithdrawnNCT01714089Phase 2
- Keratinocyte Growth Factor to Prevent Autoimmunity After Alemtuzumab Treatment of Multiple SclerosisTerminatedNCT01712945Phase 1/2
- Ginseng in Treatment of Fatigue in Multiple SclerosisCompletedNCT01712373Phase 2
- Evaluation of Coagulation in Multiple SclerosisCompletedNCT01711255
- Effect of an Individualized Patient Support Program on Treatment Satisfaction in Fingolimod-treated Patients With RRMSWithdrawnNCT01709812Phase 4
- Canadian Multicenter Observational Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsTerminatedNCT01706107
- Assessment of Strategies for the Management of Flu-like Symptoms in MS Patients Commencing Treatment With Betaferon (INFLUENCE)CompletedNCT01706055
- Impact of Vitamin A on RAR Gene Expression in Multiple SclerosisStatus unknownNCT01705457Phase 4
- Effect of Fingolimod on the Cardiac Autonomic Regulation in Patients With Multiple SclerosisCompletedNCT01704183
- Natalizumab De-escalation to Interferon-beta-1b in Patients With Relapsing-remitting Multiple SclerosisTerminatedNCT01701856Phase 4
- First-in-Human Study With GNbAC1 in Healthy VolunteersCompletedNCT01699555Phase 1
- Vestibular Rehabilitation for Persons With Multiple Sclerosis: Who Benefits the Most? (MSVR3trial)CompletedNCT01698086Not applicable
- A Longitudinal Study of Effect of Copaxone in RRMS Over 24 MonthsCompletedNCT01695434
- Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple SclerosisCompletedNCT01684761Phase 2
- High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior TreatmentTerminatedNCT01679041Phase 2
- Sacroiliitis in Systemic SclerosisCompletedNCT01673633
- Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?CompletedNCT01667497Phase 2/3
- Adderall XR and Processing Speed in Multiple Sclerosis (MS)CompletedNCT01667484Phase 2/3
- Evaluation of the Efficiency of a Cognitive Remedial Program (PROCOG-SEP) Designed for Multiple Sclerosis PatientsStatus unknownNCT01659593Not applicable
- Cognitive Evolution in Tysabri Treated Multiple Sclerosis PatientsCompletedNCT01658384
- FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of FampyraCompletedNCT01656148Phase 4
- Prognosis Value of the Neuronal Damage in Early Multiple SclerosisStatus unknownNCT01651520Not applicable
- Proof of Biological Activity of SAR100842 in Systemic SclerosisCompletedNCT01651143Phase 2
- Aerobic Exercise Training in Amyotrophic Lateral SclerosisStatus unknownNCT01650818Not applicable
- Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple SclerosisWithdrawnNCT01649050Phase 2
- Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple SclerosisCompletedNCT01647321Not applicable
- Impact of Early Non Invasive Ventilation in Amyotrophic Lateral Sclerosis (ALS) PatientsCompletedNCT01641965Not applicable
- Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01640067Phase 1
- Creation of a Bank of Fibroblast From Patients With Amyotrophic Lateral Sclerosis: Pilot StudyCompletedNCT01639391Not applicable
- Safety Study of GNbAC1 in Multiple Sclerosis PatientsCompletedNCT01639300Phase 2
- Evaluating Intervention Responsiveness in People With Multiple SclerosisCompletedNCT01632293Not applicable
- Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) StudyCompletedNCT01628315
- Brain Functional Connectivity Changes Following Cognitive Rehabilitation in Multiple Sclerosis: an fMRI StudyCompletedNCT01628276Not applicable
- Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in CombinationStatus unknownNCT01627938Phase 2
- Analysis of Lymphocyte Cell Surface Adhesion Marker Expression in Natalizumab Population With Active ControlCompletedNCT01626248
- Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced SubjectsStatus unknownNCT01624714Phase 1
- ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against InterferonWithdrawnNCT01621269Phase 4
- The Role of Exercise in Modifying Outcomes for People With Multiple SclerosisStatus unknownNCT01611987Not applicable
- A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral SclerosisCompletedNCT01609283Phase 1
- Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral SclerosisCompletedNCT01605006Not applicable
- Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) PatientsCompletedNCT01601119
- An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection DeviceCompletedNCT01601080
- Exploratory Study to Assess the Effect of Fampridine (BIIB041) on Walking Ability and Balance in Participants With Multiple Sclerosis.CompletedNCT01597297Phase 2
- Using Optical Coherence Tomography to Capture Retinal Microvascular Changes Associated With Multiple SclerosisCompletedNCT01596881
- A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker DiscoveryCompletedNCT01592552
- Evaluation of Brain Atrophy in CIS Patients on AvonexCompletedNCT01592474
- Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMSCompletedNCT01592097
- Hyperlipidemia and Statin Therapy in Amyotrophic Lateral SclerosisCompletedNCT01592084
- NAPS-MS: NAtalizumab Effects on Parameters of Sleep in Patients With Multiple Sclerosis Experiencing Fatigue or SleepinessCompletedNCT01591551Phase 4
- Immune Regulation in Multiple Sclerosis: MicroRNA and Antigen-Presenting CellsCompletedNCT01587690
- Serial Night Time Position Splint on Systemic SclerosisStatus unknownNCT01586663Phase 3
- Early Stage Amyotrophic Lateral Sclerosis Phrenic StimulationTerminatedNCT01583088Phase 3
- Group Balance Training for People With Multiple SclerosisCompletedNCT01582126Not applicable